GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Operating Expense

ANL (Adlai Nortye) Other Operating Expense : $-0.35 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Other Operating Expense?

Adlai Nortye's Other Operating Expense for the three months ended in Jun. 2024 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.35 Mil.

Adlai Nortye's quarterly Other Operating Expense increased from Jun. 2023 ($-0.16 Mil) to Dec. 2023 ($0.00 Mil) but then stayed the same from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($0.00 Mil).

Adlai Nortye's annual Other Operating Expense declined from Dec. 2021 ($-0.18 Mil) to Dec. 2022 ($-0.26 Mil) and declined from Dec. 2022 ($-0.26 Mil) to Dec. 2023 ($-0.89 Mil).

Adlai Nortye Other Operating Expense Historical Data

The historical data trend for Adlai Nortye's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Other Operating Expense Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Other Operating Expense
-0.18 -0.26 -0.89

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Other Operating Expense Get a 7-Day Free Trial - -0.19 -0.16 - -

Adlai Nortye Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Operating Expense
Comparable Companies
MGTX KALV JANX AVTE ABUS VYGR BLUE AGEN FUSN CRBU OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N2U0:Germany
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.